Fool.com
The World's Greatest Investing Community
Results 21 - 30 of 608 : Previous 1 2 3 4 5 6 7 8 9 Next
Drug Companies Should Think Smaller
Sanofi-aventis looks to break R&D into smaller chunks.
Talecris Biotherapeutics Holdings introduces itself to investors with a bloody good third quarter.
Now That's What I Call a Drug Deal
Regenerating interest in Regeneron.
Dream Stocks for Dividend Investors
Make finding the best dividend stocks a reality.
Small Acquisitions and the Road to Success
Bristol-Myers is taking a different route to bulk up.
Should You Buy Stocks, Bonds, or Gold?
All are going up. Which will go down?
3 Companies Looking for Gratitude Early
Their drugs will have to get past the FDA first.
A Million Dollars and Not Even 60 Yet
Here's how one couple got rich (sort of) quick -- and how you might, too.
A Big Upgrade for Gilead Sciences
This bullish call comes from more than just one analyst.
Gone but not forgotten, in semi-free verse.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK